1
Clinical Trials associated with Iodixanol LiposomalPhase 1 Single Dose, Double-blind, Dose-escalation, Safety, Tolerability and Pharmacokinetic Study of NCTX (PEGylated Liposomal Iodixanol Injection) in Healthy Volunteers
This is a randomized, double-blind, single dose, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of NCTX (PEGylated Liposomal Iodixanol Injection) administered intravenously to healthy volunteers. In addition, computed tomography (CT) scans will be acquired to measure radiographic density in regions of interest (ROI) at times from 3-5 hours and up to 72 hours following NCTX administration.
100 Clinical Results associated with Iodixanol Liposomal
100 Translational Medicine associated with Iodixanol Liposomal
100 Patents (Medical) associated with Iodixanol Liposomal
100 Deals associated with Iodixanol Liposomal